Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132409) titled 'Interleukin-1 Inhibitor for Refractory CTD-ILD: A Clinical Observational Study and Mechanistic Investigation' on Sept. 14.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Nanjing Drum Tower Hospital
Condition:
Connective tissue disease-associated interstitial lung disease
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Study cohort:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334417
Published by HT Digital Content Services with permission from Health Daily Dige...